Oral administration of pyrophosphate inhibits connective tissue calcification
Dóra Dedinszki, Flóra Szeri, Eszter Kozák, Viola Pomozi, Natália Tőkési, Tamás Róbert Mezei, Kinga Merczel, Emmanuel Letavernier, Ellie Tang, Olivier Le Saux, Tamás Arányi, Koen van de Wetering, András Váradi, Dóra Dedinszki, Flóra Szeri, Eszter Kozák, Viola Pomozi, Natália Tőkési, Tamás Róbert Mezei, Kinga Merczel, Emmanuel Letavernier, Ellie Tang, Olivier Le Saux, Tamás Arányi, Koen van de Wetering, András Váradi
Abstract
Various disorders including pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI), which are caused by inactivating mutations in ABCC6 and ENPP1, respectively, present with extensive tissue calcification due to reduced plasma pyrophosphate (PPi). However, it has always been assumed that the bioavailability of orally administered PPi is negligible. Here, we demonstrate increased PPi concentration in the circulation of humans after oral PPi administration. Furthermore, in mouse models of PXE and GACI, oral PPi provided via drinking water attenuated their ectopic calcification phenotype. Noticeably, provision of drinking water with 0.3 mM PPi to mice heterozygous for inactivating mutations in Enpp1 during pregnancy robustly inhibited ectopic calcification in their Enpp1-/- offspring. Our work shows that orally administered PPi is readily absorbed in humans and mice and inhibits connective tissue calcification in mouse models of PXE and GACI PPi, which is recognized as safe by the FDA, therefore not only has great potential as an effective and extremely low-cost treatment for these currently intractable genetic disorders, but also in other conditions involving connective tissue calcification.
Keywords: generalized arterial calcification of infancy; oral pyrophosphate treatment; pseudoxanthoma elasticum; soft tissue calcification.
© 2017 Institute of Enzymology, RCNS, Hungarian Academy of Sciences Published under the terms of the CC BY 4.0 license.
Figures
References
- Aessopos A, Savvides P, Stamatelos G, Tassiopoulos T, Kaklamanis P, Fessas P, Rombos L, Karagiorga M (1992) Pseudoxanthoma elasticum‐like skin lesions and angioid streaks in β‐thalassemia. Am J Hematol 41: 159–164
- Aherrahrou Z (2003) Histological and molecular genetic analysis of mice with genetic predisposition to dystrophic cardiac calcification in response to injury. PhD Dissertation, Faculty of Medicine, University of Lübeck, Germany;
- Bergen AAB, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F et al (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25: 228–231
- Brampton C, Aherrahrou Z, Chen LH, Martin L, Bergen AAB, Gorgels TGMF, Erdfdi J, Schunkert H, Szabó Z, Váradi A et al (2014) The level of hepatic ABCC6 expression determines the severity of calcification after cardiac injury. Am J Pathol 184: 159–170
- Doehring LC, Kaczmarek PM, Ehlers EM, Mayer B, Erdmann J, Schunkert H, Aherrahrou Z (2006) Arterial calcification in mice after freeze‐thaw injury. Ann Anat 188: 235–242
- Ferguson A, Watson WC, Maxwell JD, Fell GS (1968) Alkaline phosphatase levels in normal and diseased small bowel. Gut 9: 96–98
- Gorgels TGMF, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PTVM, van Kuppevelt TH, Levelt CN, de Wolf A, Loves WJP et al (2005) Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14: 1763–1773
- Ho AM, Johnson MD, Kingsley DM (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289: 265–270
- Hoeg JM, Feuerstein IM, Tucker EE (1994) Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 14: 1066–1074
- Jackson WM, Aragon AB, Bulken‐Hoover JD, Nesti LJ, Tuan RS (2009) Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res 27: 1645–1651
- Jansen RS, Küçükosmanoğlu A, de Haas M, Sapthu S, Otero JA, Hegman IEM, Bergen AAB, Gorgels TGMF, Borst P, van de Wetering K (2013) ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci USA 110: 20206–20211
- Jansen RS, Duijst S, Mahakena S, Sommer D, Szeri F, Váradi A, Plomp A, Bergen AA, Elferink RPJO, Borst P et al (2014) ABCC6‐mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation. Arterioscler Thromb Vasc Biol 34: 1985–1989
- Kalal IG, Seetha D, Panda A, Nitschke Y, Rutsch F (2012) Molecular diagnosis of generalized arterial calcification of infancy (GACI). J Cardiovasc Dis Res 3: 150–154
- Kauffenstein G, Pizard A, Le Corre Y, Vessiéres E, Grimaud L, Toutain B, Labat C, Mauras Y, Gorgels TG, Bergen AA et al (2014) Disseminated arterial calcification and enhanced myogenic response are associated with Abcc6 deficiency in a mouse model of pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol 34: 1045–1056
- Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen L, Birk DE, Sundberg JP et al (2005) Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25: 8299–8310
- Kreines K, Johnson E, Albrink M, Knatterud GL, Levin ME, Lewitan A, Newberry W, Rose FA (1985) The course of peripheral vascular disease in non‐insulin‐dependent diabetes. Diabetes Care 8: 235–843
- Le Saux O, Urban ZS, Tschuch C, Csiszar K, Bacchelli B, Quaglino D, Pasquali‐Ronchetti I, Pope FM, Richards A, Terry S et al (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25: 223–227
- Letavernier E, Verrier C, Goussard F, Perez J, Huguet L, Haymann JP, Baud L , Bazin D, Daudon M (2016) Calcium and Vitamin D have a synergistic role in a rat model of kidney stone disease. Kidney Int 90: 809–817
- Moe SM, Chen NX (2004) Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95: 560–567
- Nitschke Y, Rutsch F (2012) Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc Med 22: 145–149
- Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S (1998) Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 19: 271–273
- O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79: 512–517
- Orriss IR, Arnett TR, Russell RGG (2016) Pyrophosphate: a key inhibitor of mineralisation. Curr Opin Pharmacol 28: 57–68
- Pomozi V, Brampton C, van de Wetering K, Zoll J, Calio B, Pham K, Owens JB, Mart J, Moisyadi S, Váradi A et al (2017) Pyrophosphate supplementation prevents chronic and acute calcification in ABCC6‐deficient mice. Am J Pathol 187: 1258–1272
- Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP‐binding cassette (ABC) transporter. Proc Natl Acad Sci USA 97: 6001–6006
- Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, Schauer G, Lehmann M, Roscioli T, Schnabel D et al (2003) Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet 34: 379–381
- Schindelin J, Arganda‐Carreras I, Frise E, Kayning V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open‐source platform for biological‐image analysis. Nat Methods 9: 676–682
Source: PubMed